The distribution of the messenger RNA encoding the dopamine D5 receptor was determined in the rat brain by in situ hybridization. Using [~sS]-Iabelled riboprobes to either the rat or human D 5 receptor, this mRNA was localized to the hippocampus and the parafascicular nucleus of the thalamus. This mRNA could not be visualized in the more traditional brain regions associated with dopaminergic cell bodies or projection fields. This unusual distribution suggests a novel function in the brain for this subtype of the dopamine receptor.
The recent cloning of multiple subtypes of the dopamine receptor has revealed at least five distinct receptors, which cluster into Dl-like and DMike families [2, 4 , 7, 17, 21 25, 28, 29] . The D2 family consists olD 2 [2] , D 3 [7, 21] and D~ [25] receptors. All three of these receptors have D~-like pharmacology, with subtle between-receptor differences. In particular, the 0 4 receptor has a 10-['old greater affinity for the atypical neuroleptic clozapine compared to the D2 receptor, but both receptors have comparable affinities for spiperone [25] . The distributions in brain of the mRNAs encoding these receptors are also distinctive. D 2 receptor mRNA is localized in most of the traditional motor and limbic dopaminoceprive regions of the brain, as well in several of the dopamine-containing cell groups, reflecting autoreceptor synthesis [1, 10, 12 15, 18, 26] . D 3 receptor mRNA has a more limbic distribution, with minimal localization in the deep grey motor nuclei [1] . The D 4 receptor message appears to have a cortical, limbic and hypothalamic distribution [25] .
The D~ family of dopamine receptors at present contains only two members, the D~ [4, 17, 23, 29] and D5 [22, 24, 28] (also named D~A and Dl~, resp.) subtypes. Both of these receptors have fairly similar D~-like pharmacology, although the D 5 receptor has a higher affinity for dopa-mine itself than the D l receptor [22, 24] . The mRNA encoding the D~ receptor is widely distributed in brain, very much in parallel with the distribution of the D~ receptor in the dopaminoceptive regions of the central nervous system, although not in the dopamine-containing cell regions [5, 11, 14, 16, 27] . The distribution of D~ receptor mRNA in brain is less clear.
In the original paper describing the cloning of the human D5 receptor [22] , in situ hybridization and Northern analysis using oligonucleotide probes suggested that the mRNA for this receptor is distributed in a number of motor and limbic regions of the rat brain, indistinguishable from the previously described distribution of the mRNA encoding the Dl receptor. Subsequently, the rat homolog of the human D5 receptor was cloned and referred to as D~B [24] . In contrast to the earlier report using oligonucleotides to the human D~ sequence, the distribution of the D~n receptor mRNA in the rat brain was reported as quite restricted, occurring only in the hippocampus, lateral mammilary nuclei, and a thalamic nucleus identified as the anterior pretectal nucleus. Based on the high degree of homology between these two sequences, it is likely that they are encoding the same functional receptor in the respective species from which they were cloned. Accordingly, it would be expected that the anatomical distributions demonstrated in the rat brain in these earlier two reports should be identical. Given the marked discrepancies in the anatomical distributions reported, the purpose of the present study was to reexamine the distribution of the mRNA encoding the D~/D~B 2lit receplor in the rat brain in an attempt to res()lve lhis inconsistency, using in situ hybridization with both ral and human probes.
Brains were rapidly removed from male Sprague Dawley rats (250 g) that had been sacrificed by decapitation, and were frozen in isopentane (-300(TM) for 30 s. Frozen tissue samples were cryostat-sectioned (15/,rn) and thaw-mounted onto polylysine-subbed microscope slides. Sections were obtained in a coronal plane from the fi'ontal pole (rostral to the caudate-putamen), to just caudal to the substantia nigra. These sections were maintained at -80°C until the time of hybridization.
Riboprobes complementary to human D 5 receptor mRNA were synthesized from a partial [)5 receptor cDNA. A 1,560 bp insert corresponding to the region of the human D 5 receptor spanning transmembrane domains I VH was synthesized using PCR and spliced into the Sa/I site of pGEM-3Z. This plasmid was linearized with Pstl, to result in a 800 bp probe corresponding to most of the third cytoplasmic loop and transmembrane domains VI and VIi. Riboprobes complementary to rat D 5 receptor mRNA were generated from a partial D 5 receptor cDNA corresponding to transmembrane domains II-VI subcloned into pGEM-3Z. This plasmid was linearized with ,Fall to generate a 650 bp probe. To generate antisense riboprobes, I ¢tg of these linearized DNAs were labelled with 250 ,uCi of [35S]UTP using T7 RNA polymerase. The probes were synthesized and purified as previously described for other dopamine receptor riboprobes [10 14] .
For in situ hybridization, slides at -80°C were fixed and pre-hybridized as we have previously described [10--14] . Sections were hybridized with the [3~S]-tabelled riboprobes overnight at 55°C. Probes were diluted in hybridization buffer to a final concentration of 1 2 × 106 dpm/ 30 pl. The hybridization buffer was 75% (v/v) forrnamide for the rat probe, 50% formamide for the human probe; 10% (w/v) dextran sulfate; 3 × SSC: 50 mM sodium phosphate, pH 7.4:1 x Denhardt's solution (0.02% polyvinyl pyrrolidone, 0.02% Ficoll, 0.02% bovine serum albumin); 0.l mg/ml yeast tRNA: and 10 mM dithiothreitol. Diluted probe was applied to prehybridized tissue sections, covered with a glass cover slip, and sealed with rubber cement. Following hybridization, the cover slips were removed. The sections were first rinsed in 2 × SSC at room temperature for 5 rain, then in RNAse A (200 /lg/ml in 10 mM Tris, 0.5 M NaC1, pH 8.0) for 60 min at 37°C, 2 x SSC at room temperature for 10 rain, 1 x SSC at room temperature for 10 min, 0.5 x SSC at 55°C for 1 h, and a final rinse in 0.5 x SSC at room temperature. These slides were dehydrated in graded ethanols and airdried. Slides were then apposed to X-ray film, or emulsion-dipped in NTB-2 emulsion.
Using both human and rat probes, ,mt? t~o structures were identified to contain [)5 recepto~ mRNA in a con> prehensive survey through the rat brain, as shown in t'ig. 1 , The hippocampus showed low, levels of [,)5 receplor mRNA. In addition, the paral;ascicular nucleus of the thalamus was visualized. No other structures could be identified to contain I)~ receptor mRNA, including the striatum, cortex, amygdala, olfactory tubercle, nucleus accumbens and septum, or any of the dopamine-containing cell groups such as the substantia nigra, ventral legmental area, or zona incerta. Control experiments using 'sense'-strand riboprobes or pretreatment with RNase A [10, 14] resulted in no detectable signal in these positively labelled regions.
These results are relatively similar to those reported by Tiberi et al. [24] in the rat Ds (D~R) cloning report, but are discrepant from the Sunahara et al. [22] cloning study of the human Ds receptor. In the former paper, only the hippocampus, lateral mammalary nuclei and a thalamic nucleus which was identified as the anterior pretectal nucleus were identified as Ds positive. Review of the relevant figure in this report indicates that these authors visualized the same thalamic nucleus that is demonstrated in the present report. Our identificalion of this nucleus as the parafascicular nucleus rather than the anterior pretectal nucleus is based on its histological appearance, especially its envelopment of the fasciculus retroflexus. This distinction is of significance, as these two nuclei have distinct circuitry and function.
In contrast, the Sunahara et al. study reported an anatomical distribution that suggested that this mRNA was distributed more widely, corresponding to the previously reported distribution of D~ receptor mRNA. The difference between these reports is that the Sunahara et al. study employed short oligonucleotide probes rather than longer riboprobes, which likely hybridized with authentic D~ receptor mRNA instead of (or m addition to) D 5 receptor mRNA, hence the apparent widespread distribution.
More recently, several pseudogenes of the D s receptor have been reported in the human in addition to the gene encoding the functional receptor [8, 19. 28 ]. It appears that these pseudogenes arose late in evolution, and are not identifiable in the rat [8. 28] . Accordingly, it is unlikely that detection of the distribution of Ds receptor mRNA in the rat brain is confounded by possible transcription of a pseudogene. In contrast, at least one pseudogene may be transcribed in the human, thus potentially complicating detection of the distribution of D~ receptor mRNA in the human brain [8, 28] .
The restricted distribution of D~ receptor mRNA in the rat brain suggests that this receptor may have a function distinct from the other identified dopamine recep- lors. While all of the dopamine receptors are apparently encoded in regions of the hippocampus, this is the first dopamine receptor that has been identified as being encoded in the parafascicular nucleus. This particular nucleus receives afferents from the substantia nigra [3] , making it a likely recipient of the dopamine projections arising in the midbrain. It also sends a projection to the striatum [9] , lhus suggesting a possible role for this struclure in the integration and regulation of multiple levels of dopaminergic neurotransmission. This thalamic nucleus is involved in the perception of pain [6] , and appears to be a neuroanatomical locus associated with the antinocioceptive actions of opiates [20] . The localization of D 5 receptor mRNA in this nucleus suggests that this receptor subtype may be involved in the neurochemical regulation of the thalamic processing of painful stimuli, which would not be considered a traditional role for dopamine in the central nervous system. In summary, using both rat and human riboprobes generated to the D 5 dopanaine receptor, we have determined the distribution of the mRNA encoding this receptor in the rat brain, and could only identil'y this mRNA by in situ hybridization in the hippocampus and in the parafascicular nucleus of the thalamus. This restricted distribution suggests that the D~ receptor may haxe a function quite dissimilar from other dopamine recept,~rs. 
